ALXO vs INCY · $207.2M cap vs P/E 14, rev $5.14B
Alx Oncology Holdings (ALXO) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
ALXO does not have a complete income-statement cache yet.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ALXO currently screens at market cap $207.2M. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ALXO and INCY stock pages for the full models.
Not investment advice.